{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:11:06Z","timestamp":1794035466344,"version":"4.8.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA283892"],"award-info":[{"award-number":["R35CA283892"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U42OD011023"],"award-info":[{"award-number":["U42OD011023"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P51OD011132"],"award-info":[{"award-number":["P51OD011132"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xcrm.2026.102847","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:50:41Z","timestamp":1780584641000},"page":"102847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-615X","authenticated-orcid":false,"given":"Ross T.","family":"Cromarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien A.","family":"Clain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Soigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumpa","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Eungard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Bjorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Felices","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Schacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Paiardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102847_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v11030200","article-title":"Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART","volume":"11","author":"Zicari","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2026.102847_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1159278","article-title":"Editorial: Innate immune responses in HIV controllers","volume":"14","author":"Thobakgale","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.858383","article-title":"Learning to Be Elite: Lessons From HIV-1 Controllers and Animal Models on Trained Innate Immunity and Virus Suppression","volume":"13","author":"Sugawara","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/COH.0000000000000693","article-title":"Immunological effector mechanisms in HIV-1 elite controllers","volume":"16","author":"Hartana","year":"2021","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.xcrm.2026.102847_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2016.00235","article-title":"\u201cNatural Regulators\u201d: NK Cells as Modulators of T Cell Immunity","volume":"7","author":"Schuster","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/JLB.3MR0820-685R","article-title":"Regulatory functions of NK cells during infections and cancer","volume":"109","author":"Zwirner","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.102847_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/JLB.MR0618-224RR","article-title":"From the \u201cmissing self\u201d hypothesis to adaptive NK cells: Insights of NK cell-mediated effector functions in immune surveillance","volume":"105","author":"Cruz-Mu\u00f1oz","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.102847_bib8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.102847_bib9","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1111\/febs.16073","article-title":"Natural killer cell effector functions in antiviral defense","volume":"289","author":"Piersma","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.xcrm.2026.102847_bib10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.micinf.2012.05.001","article-title":"Evasion from NK cell-mediated immune responses by HIV-1","volume":"14","author":"Jost","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.xcrm.2026.102847_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11904-016-0310-3","article-title":"NK Cells in HIV Disease","volume":"13","author":"Scully","year":"2016","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.xcrm.2026.102847_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/v14061143","article-title":"NK Cells in Protection from HIV Infection","volume":"14","author":"Bernard","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2026.102847_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005421","article-title":"A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A\/CD94-Bearing Natural Killer Cells","volume":"12","author":"Davis","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102847_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.879124","article-title":"Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control","volume":"13","author":"Bernard","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib15","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1086\/425582","article-title":"Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads","volume":"190","author":"Nag","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.xcrm.2026.102847_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imm.12016","article-title":"Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection","volume":"138","author":"Wren","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2026.102847_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102847_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac7732","article-title":"Immune correlates of vaccine protection against HIV-1 acquisition","volume":"7","author":"Corey","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib19","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1089\/aid.2012.0103","article-title":"The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120","volume":"28","author":"Karasavvas","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.xcrm.2026.102847_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib23","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1073\/pnas.2336091100","article-title":"Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates","volume":"100","author":"Mavilio","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102847_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2019.02.010","article-title":"Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort","volume":"201","author":"Nabatanzi","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COH.0000000000000600","article-title":"Broadly neutralizing antibodies for the treatment and prevention of HIV infection","volume":"15","author":"Caskey","year":"2020","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.xcrm.2026.102847_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib28","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1073\/pnas.1200024109","article-title":"Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody","volume":"109","author":"Tudor","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102847_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008064","article-title":"IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody","volume":"15","author":"Richardson","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102847_bib30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2020.00740","article-title":"FcgammaR Binding and ADCC Activity of Human IgG Allotypes","volume":"11","author":"de Taeye","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104651118","article-title":"Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody","volume":"118","author":"Meijers","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102847_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.immuni.2018.12.017","article-title":"An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes","volume":"50","author":"Dingens","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102847_bib33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib35","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1128\/JVI.05119-11","article-title":"Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens","volume":"85","author":"Chen","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.102847_bib36","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1073\/pnas.92.14.6444","article-title":"Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120","volume":"92","author":"Sakihama","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102847_bib37","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1002\/j.1460-2075.1989.tb08487.x","article-title":"Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule","volume":"8","author":"Lamarre","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2026.102847_bib38","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/JVI.02566-13","article-title":"Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains","volume":"88","author":"Chen","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.102847_bib39","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.3390\/v13091750","article-title":"Therapeutic Potential of IL-15 and N-803 in HIV\/SIV Infection","volume":"13","author":"Harwood","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2026.102847_bib40","article-title":"Immunomodulation with IL-7 and IL-15 in HIV-1 infection","volume":"9","author":"Gunst","year":"2023","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.xcrm.2026.102847_bib41","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4049\/jimmunol.1701614","article-title":"IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production","volume":"200","author":"Wagstaffe","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/infdis\/jiac103","article-title":"Mitochondrial Dysfunction Contributes to Impaired Cytokine Production of CD56bright Natural Killer Cells From Human Immunodeficiency Virus-Infected Individuals Under Effective Antiretroviral Therapy","volume":"226","author":"ToVinh","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.xcrm.2026.102847_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173099","article-title":"IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection","volume":"9","author":"Moreno-Cubero","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102847_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40291-021-00550-6","article-title":"Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy","volume":"25","author":"Phung","year":"2021","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.xcrm.2026.102847_bib45","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1158\/1078-0432.CCR-15-2710","article-title":"IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function","volume":"22","author":"Vallera","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102847_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-4939-3684-7_28","article-title":"Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells","volume":"1441","author":"Felices","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.102847_bib47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4161\/mabs.3.6.18123","article-title":"A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens","volume":"3","author":"Moore","year":"2011","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2026.102847_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib49","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/2326-6066.CIR-19-0837","article-title":"Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager","volume":"8","author":"Felices","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102847_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12985-016-0637-9","article-title":"Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412","volume":"13","author":"Ao","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.xcrm.2026.102847_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cytogfr.2006.05.001","article-title":"IL-15\/IL-15 receptor biology: a guided tour through an expanding universe","volume":"17","author":"Budagian","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.xcrm.2026.102847_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1189\/jlb.0611308","article-title":"Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through up-regulation of ICAM-1","volume":"91","author":"Wang","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.102847_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","article-title":"The role of cytokines in the regulation of NK cells in the tumor environment","volume":"117","author":"Konjevi\u0107","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2026.102847_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010052","article-title":"The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors","volume":"9","author":"Konen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.102847_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/intimm\/13.4.397","article-title":"Signaling through CD38 induces NK cell activation","volume":"13","author":"Mallone","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib56","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/blood.V94.11.3864","article-title":"CD38 triggers cytotoxic responses in activated human natural killer cells","volume":"94","author":"Sconocchia","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102847_bib57","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"Lopez-Verg\u00e8s","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102847_bib58","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib59","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/eji.202149188","article-title":"Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH","volume":"51","author":"Tomescu","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: exploration and analysis of post-cytometric complex multivariate datasets","volume":"79","author":"Roederer","year":"2011","journal-title":"Cytometry. A."},{"key":"10.1016\/j.xcrm.2026.102847_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2567.2007.02757.x","article-title":"Use of an anti-CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques","volume":"124","author":"Choi","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2026.102847_bib62","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41467-021-23189-7","article-title":"IL-21 and IFN\u03b1 therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques","volume":"12","author":"Harper","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102847_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102314","article-title":"Role of NKG2a\/c(+)CD8(+) T cells in pathogenic versus non-pathogenic SIV infections","volume":"24","author":"Huot","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2026.102847_bib64","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3389\/fimmu.2020.02134","article-title":"Non-human Primate Determinants of Natural Killer Cells in Tissues at Steady-State and During Simian Immunodeficiency Virus Infection","volume":"11","author":"Huot","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib65","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/bloodadvances.2019001110","article-title":"Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation","volume":"5","author":"Davis","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2026.102847_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113285","article-title":"The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102847_bib67","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1182\/bloodadvances.2017012369","article-title":"161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS","volume":"2","author":"Sarhan","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2026.102847_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163994","article-title":"A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer","volume":"13","author":"Vallera","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102847_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092659","article-title":"NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo","volume":"12","author":"Vallera","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102847_bib70","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1182\/bloodadvances.2018029371","article-title":"Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL","volume":"3","author":"Felices","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2026.102847_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004725","article-title":"TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity","volume":"10","author":"Kaminski","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102847_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1060905","article-title":"A tri-specific killer engager against mesothelin targets NK cells towards lung cancer","volume":"14","author":"Kennedy","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib73","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41375-020-01065-5","article-title":"A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells","volume":"35","author":"Arvindam","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2026.102847_bib74","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/2326-6066.CIR-24-0273","article-title":"A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer","volume":"13","author":"Phung","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102847_bib75","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","article-title":"Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers","volume":"23","author":"Lambotte","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2026.102847_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005042","article-title":"Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques","volume":"11","author":"Santra","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102847_bib77","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.4049\/jimmunol.174.4.2185","article-title":"Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251","volume":"174","author":"G\u00f3mez-Rom\u00e1n","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib78","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3389\/fimmu.2019.01062","article-title":"Immune Correlates of Disease Progression in Linked HIV-1 Infection","volume":"10","author":"Tuen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102847_bib80","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.01672-08","article-title":"Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques","volume":"83","author":"Hidajat","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.102847_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102847_bib82","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/637208","article-title":"Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development","volume":"2012","author":"Isitman","year":"2012","journal-title":"Adv. Virol."},{"key":"10.1016\/j.xcrm.2026.102847_bib83","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41591-022-01815-1","article-title":"Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial","volume":"28","author":"Julg","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib84","doi-asserted-by":"crossref","first-page":"E2687","DOI":"10.1073\/pnas.1506755112","article-title":"CD4 mimetics sensitize HIV-1-infected cells to ADCC","volume":"112","author":"Richard","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102847_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111983","article-title":"Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity","volume":"42","author":"Laumaea","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102847_bib86","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41586-023-06639-8","article-title":"Intermediate conformations of CD4-bound HIV-1 Env heterotrimers","volume":"623","author":"Dam","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102847_bib87","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/s41467-021-21816-x","article-title":"Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation","volume":"12","author":"Jette","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102847_bib88","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/COH.0000000000000637","article-title":"Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors","volume":"15","author":"Laumaea","year":"2020","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.xcrm.2026.102847_bib89","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1038\/s41598-017-07966-3","article-title":"One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102847_bib90","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/2326-6066.CIR-17-0550","article-title":"CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells","volume":"6","author":"Pahl","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102847_bib91","first-page":"A473","article-title":"444 GTB-3550 tri-specific killer engager TriKE\u2122 drives NK cells expansion and cytotoxicity in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients","volume":"9","author":"Felices","year":"2021","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.xcrm.2026.102847_bib92","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41591-021-01651-9","article-title":"Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial","volume":"28","author":"Miller","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib93","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.190831","article-title":"Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV","volume":"10","author":"Rhein","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102847_bib94","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/jiad578","article-title":"Safety and virologic impact of haploidentical NK cells plus IL-2 or N-803 in HIV infection","volume":"229","author":"Miller","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.xcrm.2026.102847_bib95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.20411\/pai.v1i1.100","article-title":"Defining HIV and SIV Reservoirs in Lymphoid Tissues","volume":"1","author":"Deleage","year":"2016","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.xcrm.2026.102847_bib96","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2026.102847_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1450","article-title":"Circulating CXCR5(+) natural killer cells are expanded in patients with myasthenia gravis","volume":"12","author":"Ge","year":"2023","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.xcrm.2026.102847_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155601","article-title":"Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection","volume":"7","author":"Rahman","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102847_bib99","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nm.4421","article-title":"Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys","volume":"23","author":"Huot","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102847_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01748-17","article-title":"ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment","volume":"92","author":"Ellis-Connell","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.102847_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1849","article-title":"Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments","volume":"10","author":"Kennedy","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102847_bib102","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.trecan.2022.04.008","article-title":"Hypoxia orchestrates the lymphovascular-immune ensemble in cancer","volume":"8","author":"Schito","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2026.102847_bib103","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23010-5","article-title":"Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir","volume":"12","author":"Covino","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102847_bib105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.smim.2017.07.011","article-title":"Natural killer cells unleashed: Checkpoint receptor blockade and BiKE\/TriKE utilization in NK-mediated anti-tumor immunotherapy","volume":"31","author":"Davis","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2026.102847_bib106","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.stem.2021.08.013","article-title":"Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy","volume":"28","author":"Woan","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102847_bib107","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96219","article-title":"Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect","volume":"3","author":"Felices","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102847_bib108","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2015.03.004","article-title":"Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection","volume":"161","author":"Wu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102847_bib109","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1182\/blood-2010-10-311456","article-title":"Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques","volume":"117","author":"Waldmann","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102847_bib110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.immuni.2017.09.018","article-title":"CTLA-4(+)PD-1(-) Memory CD4(+) T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques","volume":"47","author":"McGary","year":"2017","journal-title":"Immunity"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:06:02Z","timestamp":1784750762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":110,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666379126002648"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102847","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102847"}}